Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,396
Closed -$46K 1739
2025
Q4
$46K Sell
1,396
-67
-5% -$1.65K ﹤0.01% 1853
2025
Q3
$26K Hold
1,463
﹤0.01% 2018
2025
Q2
$16K Hold
1,463
﹤0.01% 2194
2025
Q1
$27K Buy
1,463
+117
+9% +$2.11K ﹤0.01% 1963
2024
Q4
$22K Hold
1,346
﹤0.01% 2071
2024
Q3
$19K Hold
1,346
﹤0.01% 2146
2024
Q2
$10K Hold
1,346
﹤0.01% 2423
2024
Q1
$11K Sell
1,346
-4,386
-77% -$39.3K ﹤0.01% 2383
2023
Q4
$39K Sell
5,732
-401
-7% -$2.23K ﹤0.01% 2353
2023
Q3
$31K Hold
6,133
﹤0.01% 2452
2023
Q2
$56K Buy
6,133
+555
+10% +$5.17K ﹤0.01% 2271
2023
Q1
$53K Sell
5,578
-851
-13% -$7.78K ﹤0.01% 2285
2022
Q4
$64K Hold
6,429
﹤0.01% 2312
2022
Q3
$77K Buy
6,429
+103
+2% +$1.03K ﹤0.01% 2266
2022
Q2
$52K Buy
6,326
+12
+0.2% +$103 ﹤0.01% 2456
2022
Q1
$50K Buy
+6,314
New +$54.5K ﹤0.01% 2483
2018
Q3
Sell
-5,084
Closed -$255K 1461
2018
Q2
$255K Buy
+5,084
New +$224K 0.01% 1426

Other funds holding AXGN

Amalgamated Bank's AXGN Position: Q1 2026 in Review

Amalgamated Bank sold out of Axogen (AXGN) in Q1 2026, closing a stake of 1,396 shares — an estimated $46K sold.

Amalgamated Bank first reported a position in AXGN in Q2 2018 and held it in 17 quarters. The position peaked at $255K in Q2 2018. 221 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • Amalgamated Bank reported no remaining Axogen position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,396 Axogen shares in Q1 2026, an estimated $46K.
  • Amalgamated Bank first reported a position in Axogen in Q2 2018 and held it in 17 quarters.
  • Amalgamated Bank's Axogen position peaked at $255K in Q2 2018.
  • 221 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.